We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
-27.87%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
–
AUM
$172M
AUM Growth
-$3.81M
Cap. Flow
+$50M
Cap. Flow %
29.05%
Top 10 Hldgs %
98.6%
Holding
13
New
2
Increased
–
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
ME
23andMe Holding Co
ME
+$46.8M
2
COIN icon
Coinbase
COIN
+$9.17M

Top Sells

Rank Stock Value
1
MQ icon
Marqeta
MQ
+$4.25M
2
VIR icon
Vir Biotechnology
VIR
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 92.5%
2 Financials 7.5%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$59.2M
$48.7M 28.27%
2,336,909
– –
ME
2
DELISTED
23andMe Holding Co
ME
$39.2M 22.8%
+512,156
New +$46.8M
FHTX icon
3
Foghorn Therapeutics
FHTX
$266M
$19.2M 11.16%
1,261,261
– –
ALEC icon
4
Alector
ALEC
$168M
$14M 8.12%
980,894
– –
NGM
5
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$11.4M 6.62%
746,674
– –
TNYA icon
6
Tenaya Therapeutics
TNYA
$161M
$10.8M 6.27%
915,705
– –
RAPT
7
DELISTED
RAPT Therapeutics
RAPT
$9.52M 5.53%
54,113
– –
COIN icon
8
Coinbase
COIN
$38.6B
$8.91M 5.18%
+46,922
New +$9.17M
FFBC icon
9
First Financial Bancorp
FFBC
$3.55B
$4M 2.33%
173,576
– –
ORIC icon
10
Oric Pharmaceuticals
ORIC
$1.15B
$3.99M 2.32%
747,550
– –
SRZN icon
11
Surrozen
SRZN
$258M
$2.42M 1.4%
53,531
– –
MQ icon
12
Marqeta
MQ
$1.83B
– –
-61,938
Closed -$4.25M
VIR icon
13
Vir Biotechnology
VIR
$1.46B
– –
-40,257
Closed -$1.69M

Similar funds

WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BWM
Buckley Wealth Management Las Vegas, Nevada $392M AUM 28.21% 1-Year Est. Return
IPW
Inlet Private Wealth Jupiter, Florida $392M AUM 25.74% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return

Euclidean Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Euclidean Capital held 13 positions worth $172M, down 2.2% from $176M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Euclidean Capital deployed $50M of net new capital in Q1 2022, opening 2 new positions. Its largest new stake was 23andMe Holding Co: 512,156 shares worth $39.2M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 95% a quarter earlier, followed by Financials and Technology.

On the sell side, the most notable exit was Marqeta, an estimated $4.25M sold.

  • Euclidean Capital's largest Q1 2022 buy was 23andMe Holding Co: 512,156 shares worth $39.2M.
  • Euclidean Capital fully exited Marqeta in Q1 2022, selling an estimated $4.25M.
  • Euclidean Capital's ten largest holdings make up 99% of its $172M portfolio in Q1 2022.
  • Euclidean Capital opened 2 new positions and closed 2 in Q1 2022.
  • Euclidean Capital's portfolio value fell 2.2% quarter-over-quarter to $172M.

Based on Euclidean Capital's 13F filing for Q1 2022, filed 16 May 2022.